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A single GAG codon deletion in the gene encoding torsinA is linked to most cases of early-onset torsion dystonia.
TorsinA is an ER-localized membrane-associated ATPase from the AAA+ superfamily with an unknown biological
function. We investigated the formation of oligomeric complexes of torsinA in cultured mammalian cells and found
that wild type torsinA associates into a complex with a molecular weight consistent with that of a homohexamer.
Interestingly, the dystonia-linked variant torsinAΔE displayed a reduced propensity to form the oligomers compared
to the wild type protein. We also discovered that the deletion of the N-terminal membrane-associating region of
torsinA abolished oligomer formation. Our results demonstrate that the dystonia-linked mutation in the torsinA
gene produces a protein variant that is deficient in maintaining its oligomeric state and suggest that ER membrane
association is required to stabilize the torsinA complex.
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Early-onset torsion dystonia (EOTD) is the most com-
mon and severe form of primary dystonia, a neurological
disorder that manifests as uncontrollable movements and
abnormal body postures. Most cases of EOTD are associ-
ated with a deletion of a single GAG codon in the DYT1
gene. As a result, a single glutamic acid residue is absent
in the EE pair located in the C-terminal region of torsinA
(Ozelius et al. 1997). TorsinA is a putative member of the
AAA+ superfamily of ATPases associated with different
activities (Neuwald et al. 1999). The torsinA mRNA is
widely expressed in various human tissues, including
the central nervous system, but the biological role of
torsinA is not completely clear (reviewed in (Tanabe
et al. 2009; Zolkiewski and Wu 2011)). AAA+ ATPases
are energy-driven “molecular machines”, which remodel
the conformation of macromolecules and disassemble
macromolecular complexes (Hanson and Whiteheart
2005). Proteins from the AAA+ family form ring-shaped
hexameric complexes, which enclose their substrate mole-
cules. Hexamer formation is essential for the activity of
AAA+ ATPases (Barnett et al. 2000). Numerous torsinA* Correspondence: michalz@ksu.edu
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in any medium, provided the original work is ppartners have been identified and the association with
some of these is compromised when the mutant gene
product is expressed (Naismith et al. 2009; Zolkiewski and
Wu 2011). However, the identity of a torsinA substrate
that is critical for its cellular activity is unknown and,
more fundamentally, whether torsinA even forms a hex-
amer in cells has not been fully established. Moreover, it is
unclear how the glutamate deletion affects these biochem-
ical properties and in turn, which defect(s) associated with
the mutant protein are linked to EOTD.
The torsinA sequence contains an N-terminal ER-
targeting signal peptide that is cleaved upon import
into the ER lumen, producing the mature 36-kDa form
of the protein (Liu et al. 2003). The signal sequence
is followed by a 20-residue-long hydrophobic segment
that is responsible for membrane association (Liu et al.
2003) and ER retention (Vander Heyden et al. 2011).
The AAA+ module of torsinA is located downstream of
the membrane-binding domain and contains a non-
canonical ATP-binding Walker-A motif (Nagy et al.
2009; Zolkiewski and Wu 2011) and six cysteines that
are absent from other AAA+ ATPases (Zhu et al. 2008;
Zolkiewski and Wu 2011). The site of the dystonia-
linked glutamate deletion (E302/E303) is located within
the C-terminal AAA+ subdomain, which supports oligo-
merization of other AAA+ ATPases (Barnett et al. 2000).en Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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a monomeric protein (Kustedjo et al. 2003; Zhu et al.
2008) or a spectrum of high-molecular weight particles
(Zhao et al. 2013). In contrast, torsinA assemblies ranging
from monomers and dimers to hexamers were detected
in lysates from mammalian cells (Kustedjo et al. 2000;
Gordon and Gonzalez-Alegre 2008; Vander Heyden et al.
2009; Jungwirth et al. 2010). How these assemblies are af-
fected by the disease-causing mutation or the hydrophobic
membrane anchor has not yet been established.
To this end, we investigated the size of human torsinA
complexes after isolation from cultured mammalian cells.
We found that the main oligomeric species is consistent
with the formation of torsinA hexamers, but this struc-
ture becomes less stable when the dystonia-linked protein
variant is expressed. We also found that the membrane-
bound hydrophobic segment stabilizes the torsinA oligo-
mer. These data add fundamental new insights to our
understanding of torsinA structure and suggest why the
loss of a single amino acid can exhibit profound cellular
effects.
Results and discussion
To determine whether human torsinA and the dystonia-
linked torsinAΔE variant oligomerize in the cell, we
expressed each protein in two cell lines, HEK293 and
CHO cells. After preparation of cell lysates in dodecyl-
maltoside, BN-PAGE and immunoblotting with an anti-
torsinA antibody was used to observe the distribution of
the torsinA-containing species (Figure 1). Both stably
transfected cell lines produced comparable amounts of
torsinA and torsinAΔE (Figure 1A, B, lower panels). In
addition to some monomeric torsinA and torsinAΔE
(shown by the bands below 66 kDa), BN-PAGE detected
a single major immunoreactive species migrating close
to the 200-kDa complex of β-amylase, but slower than the
242-kDa protein standard (Figure 1A, B, upper panels).
The migration of the torsinA oligomer in BN-PAGE is
consistent with that of a homohexamer (predicted mo-
lecular weight 216 kDa) and is consistent with the forma-
tion of a species of similar size in BN-PAGE using lysates
prepared from U2OS cells (Vander Heyden et al. 2009). It
cannot be excluded, however, that the detected species
corresponds to a hetero-oligomer containing torsinA and
other components, such as the torsinA binding partners
LAP1 and LULL1 (Goodchild and Dauer 2005; Zhao et al.
2013; Sosa et al. 2014). We also found that the deletion of
Glu302 in torsinA apparently destabilizes the oligomeric
species (Figure 1A, B, upper panels). This result suggests
that the dystonia-linked torsinA variant may be defective
in either self-association or interactions with other pro-
teins. Indeed, the efficiency of torsinAΔE interaction with
LAP1 and LULL1 is compromised relative to the wild
type protein (Naismith et al. 2009; Zhao et al. 2013). Incontrast, the dystonia-linked torsinAΔE variant shows an
enhanced binding affinity for nesprin (Nery et al. 2008).
Thus, the apparent loss of the detected oligomeric species
in the torsinAΔE producing cells (Figure 1) suggests that
the observed torsinA complex does not include nesprin.
Nevertheless, the data presented in Figure 1 indicate that
the EOTD-associated mutation has a profound effect on
oligomer and/or complex formation, and we propose that
this defect might impact the protein’s function and disease
presentation.
As noted above, previous studies on purified full-length
torsinA failed to detect oligomeric species, which could
have been the result of detergent-induced destabilization
of intersubunit contacts (Kustedjo et al. 2003). Other ex-
periments using a purified protein detected higher mo-
lecular weight species that were not further resolved
(Zhao et al. 2013). To obtain enriched soluble protein in
the absence of a detergent, we produced a truncated tor-
sinA variant lacking the hydrophobic membrane-binding
region, torsinAΔ40 (Liu et al. 2003). TorsinAΔ40 was
expressed in S2 cells and purified from the culture media
(see Materials and Methods). Interestingly, torsinAΔ40ΔE
was poorly secreted in S2 culture (Liu et al. 2003), which
is consistent with the apparent mislocalization of this dys-
tonia variant from the ER lumen to the nuclear envelope
(Goodchild and Dauer 2004; Naismith et al. 2004). The
circular dichroism spectrum of torsinAΔ40 (Figure 2A)
was similar to that of the full-length torsinA purified with
detergent (Kustedjo et al. 2003), which indicates that a de-
letion of the hydrophobic segment does not inhibit folding
of torsinA. TorsinAΔ40 was strictly monomeric (~30 kDa,
Figure 2B), regardless of whether size exclusion chroma-
tography was run in the absence of nucleotides or in the
presence of ATP or ADP, which in other cases stabilize
AAA+ hexamers (Akoev et al. 2004).
To corroborate these data, we next investigated the
oligomeric state of torsinAΔ40 in mammalian cell lysates
(Figure 2C). In contrast to the full-length protein (WT),
the torsinAΔ40 and torsinAΔ40ΔE variants again failed to
form oligomeric species in BN-PAGE. This result is in ac-
cordance with the properties of purified torsinAΔ40
(Figure 2B) and indicates that the 20 residue-long N-
terminal hydrophobic segment is essential to stabilize
torsinA complexes. Two mechanisms can be proposed
to account for this result. First, the hydrophobic seg-
ment may directly participate in either self-association
or hetero-association with another protein’s membrane-
embedded domain. Second, the membrane association
of torsinA and its retention in the ER lumen may increase
the likelihood of forming the homo- or heterooligomers.
Recently, hetero-hexamers of torsinA and LAP1 were
reconstituted with purified proteins (Sosa et al. 2014).
Since LAP1 is a transmembrane protein, its interaction
with torsinA in the cell might be efficient only if torsinA
Figure 1 BN-PAGE analysis of torsinA complexes. Full-length human torsinA (WT) or the dystonia-linked torsinAΔE protein (ΔE) was expressed
in HEK293 (A) and CHO (B) cells. Production of the torsinA variants was confirmed by SDS-PAGE followed by immunoblotting with anti-torsinA
antibodies (lower panels) using untransfected cells as a control (C). The cell lysates were separated on BN-PAGE followed by immunoblotting
(upper panels). For BN-PAGE, the migration positions of the native-electrophoresis standards are indicated. The migration position of β-amylase
(200 kDa) is indicated with an arrow. Protein migration in BN-PAGE can reflect other biophysical properties, besides the molecular weight, so the
molecular weight determination is only approximate. The figure shows a representative result from two independent experiments.
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hydrophobic segment. Future efforts will be directed to
address this hypothesis.
Conclusions
In summary, we found that torsinA forms a discrete
high-molecular weight complex in mammalian cells.
However, the complex is destabilized by the dystonia-
linked mutation, but is stabilized by the membrane an-
chor. Establishing a link between defects in torsinAΔE
oligomerization and EOTD will be an important focus
of future research efforts.Methods
Plasmids, antibodies, and reagents
DNA constructs containing the human torsinA sequence
in pcDNA3 vector were described before (Liu et al. 2003)
and anti-torsin antibodies were obtained as described
(Zacchi et al. 2014). Sweet potato β-amylase was from
Sigma. Native electrophoresis protein standards were from
Invitrogen/Life Technologies.
Cell culture
HEK293 cells were maintained in DMEM (Invitrogen)
supplemented with 10% fetal bovine serum (BioWhittaker)
Figure 2 Oligomerization of the N-terminally truncated torsinA variants. (A) Far-UV circular dichroism spectra of purified torsinAΔ40
(1 mg/ml, solid line) and the dialysis buffer (dotted line) are shown. (B) Gel-filtration analysis of torsinAΔ40 in the absence of nucleotides or in the
presence of 2 mM ATP or ADP is shown. The elution times of molecular weight standards (kDa) are indicated. (C) BN-PAGE (upper panel) and
SDS-PAGE (lower panel) analysis was followed by immunoblotting with anti-torsinA antibodies of lysates from HEK293 and CHO cells expressing
either full-length torsinA (WT), torsinAΔ40 (Δ40), torsinAΔ40ΔE (Δ40ΔE) or untransfected cells (C). For BN-PAGE, the migration positions of the
native-electrophoresis standards are indicated. The migration position of β-amylase (200 kDa) is indicated with an arrow. Protein migration in
BN-PAGE can reflect other biophysical properties, besides the molecular weight, so the molecular weight determination is only approximate. The
figure shows a representative result from two independent experiments.
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were maintained in F-12 K medium (Invitrogen) sup-
plemented with 10% fetal bovine serum. Cells were trans-
fected with pcDNA3 expression vectors containing the
torsinA variants using FuGene 6 transfection reagent
(Roche) according to the manufacturer’s instructions.
Stably transfected cells were selected in the presence of
1 mg/mL G418 (Invitrogen).
Blue-native PAGE
BN-PAGE is a native gel electrophoresis technique, where
the Coomassie Brilliant Blue dye binds to membrane pro-
tein complexes and provides the electric charge for the
electrophoretic separation. BN-PAGE was carried out as
previously described (Wittig et al. 2006; Vander Heyden
et al. 2009; Jungwirth et al. 2010). Briefly, ~90% confluent
cells were collected and solubilized in a lysis buffer
(50 mM imidazole pH 7.0, 50 mM NaCl, 2 mM 6-
aminohexanoic acid, 4 mM MgCl2, 2 mM EDTA, 2 mM
ATP, 1 mM PMSF, and 0.25% dodecylmaltoside) for
15 min in 4°C, and centrifuged twice for 15 min at
15,000 rpm in IEC Micromax benchtop centrifuge. Thesupernatant supplemented with 0.0625% Coomassie blue
G-250 and 5% glycerol was loaded onto a 9% polyacryl-
amide gel. Following electrophoresis, separated proteins
were transferred onto PVDF membrane and subjected to
immunoblotting using anti-torsinA antibodies, followed
by horseradish peroxidase-conjugated anti-rabbit IgG an-
tibodies (Southern Biotechnology). Signal detection was
performed with WestPico chemiluminescence kit (Pierce).
Protein purification
The S2 cell line stably transfected with a torsinAΔ40 ex-
pression plasmid containing the BiP signal sequence
followed by an N-terminal His-tag was produced as pre-
viously described (Liu et al. 2003). Cells were grown at
23°C in S2 medium (Invitrogen) supplemented with
0.5% DMSO when the density reached 107 cells/ml and
protein expression was induced after 24 h with 0.7 mM
CuSO4. The cells were separated from the culture me-
dium by centrifugation 6 days post induction. The me-
dium was filtered through a 0.45 μm membrane and
loaded onto a 2.5-ml Chelating Sepharose column (GE
Healthcare). Proteins were eluted with an imidazole step
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(eluted at 10–50 mM imidazole) were pooled, concen-
trated on Centriplus YM-10 (Millipore), and dialyzed in
50 mM Tris–HCl pH 7.5, 100 mM NaCl, 20 mM MgCl2,
and 10% glycerol.
Circular dichroism spectroscopy
CD spectra were measured with a Jasco J-720 spectrometer
using a 0.01-cm cylindrical cuvette at room temperature.
Gel filtration chromatography
Gel filtration analysis was performed at room tem-
perature with a Shimadzu HPLC. TorsinAΔ40 samples
(20 μl, ~0.2 mg/ml) were analyzed at 0.04 ml/min on a
Superdex 200 PC 3.2/30 column (GE Healthcare) equil-
ibrated in 50 mM Tris/HCl pH 7.5, 0.2 M KCl, 20 mM
MgCl2 without nucleotides or with 2 mM ATP or ADP.
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